Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein. 29604477 2018
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects. 17045504 2006
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; <i>SLC10A1</i>) on the sinusoidal membrane of hepatocytes. 31333191 2019
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE Here we show that a viral membrane protein, the duck hepatitis B virus (DHBV) large envelope protein (DHBs L), produced by WG-CFPS, is phosphorylated upon translation at the same sites as DHBs L produced during DHBV infection of primary hepatocytes. 31850370 2019
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. 7539089 1995
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE For the patients who showed viremia, we analyzed amino acid sequences of the HB envelope protein, and we performed a statistical analysis for the factors associated with viremia. 24961506 2014
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Expanding on our demonstration that acylated peptides derived from the large HBV envelope protein block virus entry in vitro, we show their applicability to prevent HBV or woolly monkey hepatitis B virus infection in vivo, using immunodeficient urokinase-type plasminogen activator (uPA) mice repopulated with primary human or Tupaia belangeri hepatocytes. 18297057 2008
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 AlteredExpression disease BEFREE Characterization of contrasting features between hepatitis B virus genotype A and genotype D in small envelope protein expression and surface antigen secretion. 28126637 2017
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein. 1334115 1992
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Australian antigen, the envelope protein of hepatitis B virus (HBV), was discovered in 1967 as a prevalent serum antigen in hepatitis B patients. 25833941 2015
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Altogether, specific domains and residues in the HBV S protein that are required for oligomerization and SVP generation were defined.<b>IMPORTANCE</b> The small hepatitis B virus envelope protein S has the intrinsic ability to direct the morphogenesis of spherical 20-nm subviral lipoprotein particles. 29540592 2018
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion. 30415392 2019
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE 42% (15 of 21 specimens), but there was only 40% positivity (8 of 20 specimens) for hepatitis B virus envelope antigen whereas 6 of 17 patients (35.29%) showed the presence of antibodies against hepatitis B virus envelope protein. 10738214 2000